Form 4: Jaguar Health Executive Steven R. King Reports Stock Transactions

Steven R. King, a Jaguar Health executive, reported the vesting and conversion of restricted stock units into common stock on May 17, 2024.

Summary

• On May 17, 2024, Steven R. King, Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary at Jaguar Health, Inc., reported a transaction involving restricted stock units.
• 612 restricted stock units vested and were converted into 612 shares of common stock.
• These restricted stock units vest in three equal annual installments beginning on May 17, 2023.
• The reported transaction reflects adjustments due to a 75-for-1 reverse stock split that occurred on January 23, 2023.
• Following the transaction, King directly owns 1,756 shares of Jaguar Health common stock and 612 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the conversion of existing equity-based compensation into common stock.

Key Dates

Keywords

Jaguar Health, Steven R. King, Form 4, Stock Transaction, Restricted Stock Units, Common Stock, Insider Trading